Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

    Mehrez M. Jadaon
    e2011054
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.054
    2773
    PDF: 1132
    HTML: 2810
  • EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

    Mehrez Mehrez M. Jadaon
    e2011037
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.037
    3155
    PDF: 817
    HTML: 12910
  • MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION

    Maimiza Zahari, Siti Aishah Sulaiman, Zulhabri Othman, Yasmin Ayob, Faraizah Abd Karim, Rahman Jamal
    e2018056
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.056
    2053
    PDF: 1065
    HTML: 749
    Figure 1: 161
    Figure 2: 176
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2172
    PDF: 1723
    HTML: 384
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1423
    PDF: 745
    HTML: 307
  • Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

    Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier
    e2017038
    2017-06-16
    https://doi.org/10.4084/mjhid.2017.038
    2164
    PDF: 844
    HTML: 932
    Patient’s family tree: 173
  • PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

    Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag
    e2011055
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.055
    1902
    PDF: 764
    HTML: 1534
  • BETA-GLOBIN GENE MUTATIONS IN TURKISH CHILDREN WITH BETA-THALASSEMIA: RESULTS FROM A SINGLE CENTER STUDY

    Ali Fettah, Cengiz Bayram, Nese Yarali, Pamir Isik, Abdurrahman Kara, Vildan Culha, Bahattin Tunc
    e2013055
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.055
    1678
    PDF: 699
    HTML: 1643
    Beta-globin Gene Mutations in Turkish Children with Beta-Thalassemia: Results from a Single Center Study: 191
  • DETECTION OF CALR MUTATIONS USING HIGH RESOLUTION MELTING CURVE ANALYSIS (HRM-A); APPLICATION ON A LARGE COHORT OF GREEK ET AND MF PATIENTS

    Andreas Giannopoulos, Niki Rougkala, Theodoros Loupis, Marina Mantzourani, Nora-Athina Viniou, Eleni Variami, Theodoros Vassilakopoulos, George Dryllis, Ioannis Kotsianidis, Theodora Gougopoulou, Marianna Politou, Konstantinos Konstantopoulos, George Vassilopoulos
    e2019009
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.009
    3056
    PDF: 1219
    HTML: 544
  • GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS

    Ravindra Kumar, Kritanjali Singh, Inusha Panigrahi, Sarita Agarwal
    e2013003
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.003
    1779
    PDF: 1296
    HTML: 11519
    Figure1: 180
    Figure 2: 182
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    3074
    PDF: 919
    HTML: 2050
  • THE CLINICAL SIGNIFICANCE OF THE SPECTRUM OF INTERACTIONS OF THE RARE IVS-II-5 G>C (HBB: C.315+5 G>C) VARIATION WITH OTHER Β-THALASSEMIA MUTATIONS IN SOUTHERN CHINA

    Yali Zhou, Guiping Liao, Xiaolin Yin, Sheng He, Yi Wu, Jian Xiao, Zhili Geng, Qiuying Huang, Ganghui Luo, Kun Yang
    e2022034
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.034
    1281
    PDF: 525
    HTML: 325
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    1994
    PDF: 521
    HTML: 589
  • Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients

    Yi-Chang Liu, Ching-Ping Lee, Tsung-Jang Yeh, Yuh-Ching Gau, Chieh-Yu Hsieh, Ya-Lun Ke, Jeng-Shiun Du, Ming-Hui Lin, Hui-Ching Wang, Shih-Hao Tang, Shih-Feng Cho, Jui-Feng Hsu, Samuel Yien Hsiao, Chin-Mu Hsu, Hui-Hua Hsiao
    e2020022
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.022
    1284
    PDF: 741
    HTML: 438
  • NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

    Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera
    e2020083
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.083
    1732
    PDF: 1204
    HTML: 235
  • PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY

    Mohammad Ehsan Jaripour, Kourosh Hayatigolkhatmi, Vahid Iranmanesh, Farhad Khadivi Zand, Zahra Badiei, Hamid Farhangi, Ali Ghasemi, Abdollah Banihashem, Reza Jafarzadeh Esfehani, Ariane Sadr-Nabavi
    e2018042
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.042
    2426
    PDF: 967
    HTML: 396
    Supplementary table 1: 228
    Some of the mutation detection samples: 218
  • SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

    Hanaa El-Karaksy, Mona El-Raziky
    e2011027
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.027
    2209
    PDF: 930
    HTML: 1656
  • SEQUENCE ANALYSIS OF HOT SPOT REGIONS OF SPIKE AND RNA‑DEPENDENT‑RNA POLYMERASE (RDRP) GENES OF SARS-COV-2 IN KERMAN, IRAN

    Nasir, Ramin, Amin, Jamal
    e2023042
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.042
    870
    PDF: 755
    HTML: 202
  • SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

    Zohreh Rahimi, Abbas Parsian
    e2011024
    2011-05-23
    https://doi.org/10.4084/mjhid.2011.024
    2288
    PDF: 909
    HTML: 2100
  • PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

    Maria Cristina Rosatelli, Luisella Saba
    e2009011
    2009-11-15
    1208
    PDF: 378
    HTML: 6370
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1631
    PDF: 934
    HTML: 138
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    11189
    PDF: 4382
    HTML: 4372
  • THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION

    Emmanouil Spanoudakis, Menelaos Papoutselis, Ioanna Bazntiara, Eleftheria Lamprianidou, Xrisa Kordella, Constantinos Tilkeridis, Constantinos Tsatalas, Ioannis Kotsianidis
    e2018058
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.058
    1371
    PDF: 844
    HTML: 185
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2878
    PDF: 3265
    HTML: 553
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7661
    PDF: 2448
    HTML: 1742
    Table 1.: 216
    Table 2.: 226
    Table 3.: 210
    Table 4.: 210
  • HB H DISEASE CAUSED BY UNIPARENTAL DISOMY: FIRST REPORT OF THE αT-SAUDIΑ MUTATION IN THE CHINESE POPULATION

    Ge Wang, Hongting Xie, Jun Zhang, Peng Huang, Min Liang, Dina Zhu, Qianqian Zhang, Yuqiu Zhou, Xuan Shang
    e2024069
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.069
    1040
    PDF: 616
    Html: 123
    Suppl. Files: 449
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2819
    PDF: 775
    HTML: 1281
    Blood Count trend before and during lenalidomide treatment: 176
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 198
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1581
    PDF: 1044
    HTML: 238
  • SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

    Massimo Breccia, Giuliana Alimena
    e2014003
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.003
    3296
    PDF: 1229
    HTML: 3475
  • FLT3 INTERNAL TANDEM DUPLICATION AND D835 MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CLINICAL SIGNIFICANCE

    Ghaleb Elyamany, Mohamed Awad, Omar Alsuhaibani, Kamal Fadalla, Omer Al Sharif, Mohammad Al Shahrani, Fahad Alabbas, Abdulaziz Al-Abulaaly
    e2014038
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.038
    1852
    PDF: 984
    HTML: 7174
  • Could the 3′UTR+101G>C Mutation Detected in Two Sibling Cases Be a Mutation Affecting the Clinical Presentation in Thalassemia Patients?

    Unal Atas, Volkan Karakus, Erdal Kurtoglu
    e2024023
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.023
    588
    PDF: 1084
    HTML: 101
  • NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria

    Jonathan Braue, Vagishwari Murugesan, Steven Holland, Nishit Patel, Eknath Naik, Jennifer Leiding, Abraham Tareq Yacoub, Carlos N Prieto-Granada, John Norman Greene
    e2015010
    2014-12-27
    https://doi.org/10.4084/mjhid.2015.010
    1738
    PDF: 1109
    HTML: 10706
    Untitled: 195
  • Novel deleterious sequence change in the NLRP12 gene in a child with autoinflammatory syndrome, joint hypermobility and cutis laxa from India.

    Kanjaksha Ghosh, Kanchan Mishra, Avani Shah, Parizad Patel, Shrimati Shetty
    e2019018
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.018
    1772
    PDF: 1152
    HTML: 341
  • PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA

    Monica Sharma, Sanjay Pandey, Ravi Ranjan, Tulika Seth, Renu Saxena
    e2015004
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.004
    2453
    PDF: 1240
    HTML: 4738
    table: 214
    fig 1: 224
    fig 2: 180
  • BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE

    Marzia Varettoni, Irene Defrancesco, Luca Diamanti, Enrico Marchioni, Lisa Maria Farina, Anna Pichiecchio
    e2017061
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.061
    3497
    PDF: 1511
    HTML: 1322
  • NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2

    Mohsen Nakhaei, Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Nasir
    e2023059
    2023-10-16
    https://doi.org/10.4084/MJHID.2023.059
    991
    PDF: 471
    HTML: 126
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1250
    PDF: 476
    HTML: 164
  • Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

    Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo
    e2019057
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.057
    1584
    PDF: 971
    HTML: 261
  • PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

    Fiorina Giona
    e2021069
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.069
    1880
    HTML: 1482
    PDF: 1110
  • CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA

    Valerio De Stefano, Tommaso Za, Angela Ciminello, Laura Betti, Elena Rossi
    e2011063
    2011-12-19
    https://doi.org/10.4084/mjhid.2011.063
    2636
    PDF: 945
    HTML: 3640
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1404
    HTML: 475
    PDF: 836
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1695
    PDF: 787
    HTML: 264
  • FINE MAPPING OF GLUCOSE 6 PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN RURAL AREA OF SOUTH WEST ODISHA USING THE CLINICAL, HEMATOLOGICAL AND MOLECULAR APPROACH

    Ravindra Kumar, MPSS Singh, Soumendu Mahapatra, Sonam Chourasia, Malay Kumar Tripathi, John Oommen, Praveen Kumar Bharti, Rajasubramaniam Shanmugam
    e2020015
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.015
    1777
    PDF: 1037
    HTML: 562
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    4021
    PDF: 1060
    HTML: 3604
    Untitled: 178
    Cneo. Fig.1: 115
    Untitled: 108
    Untitled: 129
    Untitled: 135
  • DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE

    Ibrahim C. Haznedaroglu
    e2015014
    2015-12-02
    https://doi.org/10.4084/mjhid.2015.014
    277698
    PDF: 1811
    HTML: 3875
  • VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

    Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
    e2009033
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.033
    2665
    PDF: 514
    HTML: 3469
  • PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

    Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro
    e2013058
    2013-09-01
    https://doi.org/10.4084/mjhid.2013.058
    3507
    PDF: 1180
    HTML: 24040
  • COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis

    Andrea Benetti, Irene Bertozzi, PhD, MD, Giulio Ceolotto, Irene Cortella, Daniela Regazzo, Giacomo Biagetti, Elisabetta Cosi, Maria Luigia Randi, MD, Prof
    e2024021
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.021
    875
    PDF: 1248
    HTML: 137
  • THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Davide Rossi, Marco Fangazio, Gianluca Gaidano
    e2012076
    2012-11-13
    https://doi.org/10.4084/mjhid.2012.076
    2285
    PDF: 897
    HTML: 2006
    Fig 1 Rossi: 185
  • EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

    Anita Nadkarni
    e2013012
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.012
    1145
    PDF: 605
    HTML: 3341
1 - 50 of 330 items 1 2 3 4 5 6 7 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.